Farther Finance Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-126
Closed 4473
2024
Q4
$0 Hold
126
﹤0.01% 4217
2024
Q3
$0 Hold
126
﹤0.01% 4167
2024
Q2
$5.41K Buy
126
+119
+1,700% +$5.05K ﹤0.01% 2363
2024
Q1
$296 Hold
7
﹤0.01% 3172
2023
Q4
$292 Hold
7
﹤0.01% 3140
2023
Q3
$264 Buy
+7
New +$263 ﹤0.01% 2414

Other funds holding TARO

Farther Finance Advisors's TARO Position: Q1 2025 in Review

Farther Finance Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2025, closing a stake of 126 shares.

Farther Finance Advisors first reported a position in TARO in Q3 2023 and held it in 6 quarters. The position peaked at $5.41K in Q2 2024. 1 fund tracked by Wall St. Rank holds TARO as of Q1 2025.

  • Farther Finance Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 126 Taro Pharmaceutical Industries Ltd. shares in Q1 2025.
  • Farther Finance Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2023 and held it in 6 quarters.
  • Farther Finance Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $5.41K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2025.

Based on Farther Finance Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.